ALDEYRA THERAPEUTICS, INC. Stock-Based Compensation
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Stock-Based Compensation of $655.45 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- ALDEYRA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.64M, a 735.86% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was -$987.55K, a 144.40% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.09M, a 13.71% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.58M, a 20.00% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $6.09M, a 23.60% decline from fiscal 2024.
- ALDEYRA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $7.97M, a 38.60% increase from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $5.75M, a 30.60% decline from fiscal 2022.
- ALDEYRA THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $8.29M, a 16.61% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 116 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $655.45K 10-Q · filed 2026-08-06 | $1.75M derived: sum of 3 quarters · filed 2026-08-06 | $4.33M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$987.55K 10-Q · filed 2026-05-07 | $102.53K derived: sum of 2 quarters · filed 2026-05-07 | $2.68M derived: sum of 3 quarters · filed 2026-05-07 | $2.88M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.67M derived: sum of 2 quarters · filed 2026-02-27 | $3.87M derived: sum of 3 quarters · filed 2026-08-06 | $6.09M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.78M derived: sum of 2 quarters · filed 2026-08-06 | $5.00M 10-Q · filed 2025-11-05 | $6.26M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $196.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.42M 10-Q · filed 2026-08-06 | $3.68M derived: sum of 3 quarters · filed 2026-08-06 | $6.91M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $2.22M 10-Q · filed 2026-05-07 | $3.49M derived: sum of 2 quarters · filed 2026-05-07 | $6.71M derived: sum of 3 quarters · filed 2026-05-07 | $8.65M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.49M derived: sum of 2 quarters · filed 2026-02-27 | $6.42M derived: sum of 3 quarters · filed 2026-02-27 | $7.97M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.16M derived: sum of 2 quarters · filed 2025-11-05 | $6.71M 10-Q · filed 2025-11-05 | $5.91M derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.48M 10-Q · filed 2025-08-07 | $2.68M derived: sum of 3 quarters · filed 2025-08-07 | $3.47M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $1.55M 10-Q · filed 2025-05-14 | $748.50K derived: sum of 2 quarters · filed 2025-05-14 | $1.54M derived: sum of 3 quarters · filed 2025-05-14 | $3.11M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$800.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$11.13K derived: sum of 2 quarters · filed 2025-02-28 | $1.56M derived: sum of 3 quarters · filed 2025-02-28 | $5.75M 10-K · filed 2025-02-28 | ||
| 2023-09-30 | $789.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.36M derived: sum of 2 quarters · filed 2024-11-07 | $6.55M 10-Q · filed 2024-11-07 | $9.37M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.76M 10-Q · filed 2024-08-01 | $8.59M derived: sum of 3 quarters · filed 2024-08-01 | $10.82M derived: sum of 4 quarters · filed 2024-08-01 | ||
| 2023-03-31 | $4.19M 10-Q · filed 2024-05-02 | $7.01M derived: sum of 2 quarters · filed 2024-05-02 | $9.25M derived: sum of 3 quarters · filed 2024-05-02 | $10.54M derived: sum of 4 quarters · filed 2024-05-02 | ||
| 2022-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $5.06M derived: sum of 2 quarters · filed 2024-03-07 | $6.35M derived: sum of 3 quarters · filed 2024-03-07 | $8.29M 10-K · filed 2024-03-07 | ||
| 2022-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $3.53M derived: sum of 2 quarters · filed 2023-11-03 | $5.47M 10-Q · filed 2023-11-03 | $6.45M derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.23M 10-Q · filed 2023-08-03 | $4.22M derived: sum of 3 quarters · filed 2023-08-03 | $5.63M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $1.94M 10-Q · filed 2023-05-04 | $2.92M derived: sum of 2 quarters · filed 2023-05-04 | $4.34M derived: sum of 3 quarters · filed 2023-05-04 | $6.66M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $984.47K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.40M derived: sum of 2 quarters · filed 2023-03-09 | $4.73M derived: sum of 3 quarters · filed 2023-03-09 | $7.11M 10-K · filed 2023-03-09 | ||
| 2021-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.74M derived: sum of 2 quarters · filed 2022-11-10 | $6.12M 10-Q · filed 2022-11-10 | $7.75M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $4.71M 10-Q · filed 2022-08-05 | $6.34M derived: sum of 3 quarters · filed 2022-08-05 | $8.09M derived: sum of 4 quarters · filed 2022-08-05 | ||
| 2021-03-31 | $2.38M 10-Q · filed 2022-05-05 | $4.01M derived: sum of 2 quarters · filed 2022-05-05 | $5.77M derived: sum of 3 quarters · filed 2022-05-05 | $7.51M derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $3.39M derived: sum of 2 quarters · filed 2022-03-17 | $5.13M derived: sum of 3 quarters · filed 2022-03-17 | $7.08M 10-K · filed 2022-03-17 | ||
| 2020-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $3.50M derived: sum of 2 quarters · filed 2021-10-28 | $5.45M 10-Q · filed 2021-10-28 | $7.40M derived: sum of 4 quarters · filed 2021-10-28 | ||
| 2020-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.70M 10-Q · filed 2021-08-05 | $5.64M derived: sum of 3 quarters · filed 2021-08-05 | $7.80M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $1.95M 10-Q · filed 2021-05-06 | $3.90M derived: sum of 2 quarters · filed 2021-05-06 | $6.06M derived: sum of 3 quarters · filed 2021-05-06 | $8.15M derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $4.10M derived: sum of 2 quarters · filed 2021-03-11 | $6.20M derived: sum of 3 quarters · filed 2021-03-11 | $8.08M 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.25M derived: sum of 2 quarters · filed 2020-11-05 | $6.13M 10-Q · filed 2020-11-05 | $7.15M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.98M 10-Q · filed 2020-08-06 | $5.00M derived: sum of 3 quarters · filed 2020-08-06 | $6.27M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $1.89M 10-Q · filed 2020-05-07 | $2.90M derived: sum of 2 quarters · filed 2020-05-07 | $4.18M derived: sum of 3 quarters · filed 2020-05-07 | $5.16M derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $2.29M derived: sum of 2 quarters · filed 2020-03-12 | $3.28M derived: sum of 3 quarters · filed 2020-03-12 | $4.14M 10-K · filed 2020-03-12 | ||
| 2018-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.26M derived: sum of 2 quarters · filed 2019-11-07 | $3.13M 10-Q · filed 2019-11-07 | $3.13M 10-Q · filed 2018-11-14 | $3.72M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $984.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.85M 10-Q · filed 2019-08-09 | $2.45M derived: sum of 3 quarters · filed 2019-08-09 | $3.10M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $868.41K 10-Q · filed 2019-05-10 | $1.46M derived: sum of 2 quarters · filed 2019-05-10 | $2.12M derived: sum of 3 quarters · filed 2019-05-10 | $2.73M derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $592.17K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $1.25M derived: sum of 2 quarters · filed 2019-03-08 | $1.86M derived: sum of 3 quarters · filed 2019-03-08 | $2.71M 10-K · filed 2019-03-08 | ||
| 2017-09-30 | $659.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.26M derived: sum of 2 quarters · filed 2018-11-14 | $2.12M 10-Q · filed 2018-11-14 | $2.72M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $605.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.46M 10-Q · filed 2018-08-09 | $2.06M derived: sum of 3 quarters · filed 2018-08-09 | $2.94M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | $858.10K 10-Q · filed 2018-05-15 | $1.46M derived: sum of 2 quarters · filed 2018-03-29 | $2.34M derived: sum of 3 quarters · filed 2018-03-29 | $3.01M derived: sum of 4 quarters · filed 2018-03-29 | ||
| 2016-12-31 | $600.04K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $1.48M derived: sum of 2 quarters · filed 2018-03-29 | $2.15M derived: sum of 3 quarters · filed 2018-03-29 | $2.76M 10-K · filed 2018-03-29 | ||
| 2016-09-30 | $877.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.55M derived: sum of 2 quarters · filed 2017-11-09 | $2.16M 10-Q · filed 2017-11-09 | $2.71M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $673.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $1.28M 10-Q · filed 2017-08-07 | $1.83M derived: sum of 3 quarters · filed 2017-05-15 | $2.37M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2016-03-31 | $609.11K 10-Q · filed 2017-05-15 | $1.16M derived: sum of 2 quarters · filed 2017-05-15 | $1.69M derived: sum of 3 quarters · filed 2017-05-15 | $2.16M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $547.17K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $1.08M derived: sum of 2 quarters · filed 2017-03-30 | $1.55M derived: sum of 3 quarters · filed 2017-03-30 | $2.19M 10-K · filed 2017-03-30 | ||
| 2015-09-30 | $536.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $999.86K derived: sum of 2 quarters · filed 2016-11-14 | $1.64M 10-Q · filed 2016-11-14 | $2.11M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $463.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $1.10M 10-Q · filed 2016-08-10 | $1.57M derived: sum of 3 quarters · filed 2016-08-10 | $2.03M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2015-03-31 | $640.07K 10-Q · filed 2016-05-09 | $1.11M derived: sum of 2 quarters · filed 2016-05-09 | $1.56M derived: sum of 3 quarters · filed 2016-05-09 | $2.31M derived: sum of 4 quarters · filed 2016-05-09 | ||
| 2014-12-31 | $465.18K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $922.97K derived: sum of 2 quarters · filed 2016-03-30 | $1.67M derived: sum of 3 quarters · filed 2016-03-30 | $2.04M 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $457.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $1.21M derived: sum of 2 quarters · filed 2015-11-13 | $1.57M 10-Q · filed 2015-11-13 | $1.95M derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $748.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $1.11M 10-Q · filed 2015-08-14 | $1.49M derived: sum of 3 quarters · filed 2015-08-14 | $2.14M derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $365.69K 10-Q · filed 2015-05-14 | $738.92K derived: sum of 2 quarters · filed 2015-05-14 | $1.39M derived: sum of 3 quarters · filed 2015-05-14 | $2.02M derived: sum of 4 quarters · filed 2015-05-14 | $2.37M 10-Q · filed 2014-06-11 | |
| 2013-12-31 | $373.24K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $1.03M derived: sum of 2 quarters · filed 2015-03-23 | $1.65M derived: sum of 3 quarters · filed 2015-03-23 | $1.70M 10-K · filed 2015-03-23 | ||
| 2013-09-30 | $653.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $1.28M derived: sum of 2 quarters · filed 2014-11-12 | $1.33M 10-Q · filed 2014-11-12 | |||
| 2013-06-30 | $624.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $674.82K 10-Q · filed 2014-08-07 | ||||
| 2013-03-31 | $50.45K 10-Q · filed 2014-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |